Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline for prevention of cisplatin-associated nephrotoxicity
2006-003014-18Phase 3Terminated
- Sponsor
- Vicente Barrio Lucia
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nephrotoxicity comparing Theophylline + cisplatin-based chemotherapy with Placebo + cisplatin-based chemotherapy (2 arms). Primary endpoint: Prevention of decline in glomerular filtration rate. Started Dec 2011; status: terminated.
02
Drugs
theophylline
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on 2006-003014-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003014-18.